Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard’s small molecule product candidates are based on more than 20 years of GPCR research. Longboard plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. Longboard recently reported positive topline data from a Phase 1b/2a clinical trial (the PACIFIC Study) evaluating bexicaserin in participants ages 12 to 65 years old with Developmental and Epileptic Encephalopathies (DEEs), including Lennox-Gastaut syndrome, Dravet syndrome and other DEEs. Longboard is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions.
Company Details
- Employees
- 37
- Founded
- -
- Address
- 4275 Executive Square,
- Phone
- (619) 592-9775
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- longboardpharma.com
- Keywords
- Representative jobs.
- HQ
- La Jolla, CA
Longboard Pharmaceuticals Questions
Longboard Pharmaceuticals's helpline number is (619) 592-9775
Longboard Pharmaceuticals's website is longboardpharma.com
Longboard Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/longboard-pharma
Longboard Pharmaceuticals has
37 employees.
View email and phone details for 37
employees at Longboard Pharmaceuticals.
Longboard Pharmaceuticals's industry is
Biotechnology Research
Longboard Pharmaceuticals's top competitors are
Avidity Biosciences, Inc.,
Poseida Therapeutics, Inc.,
Lundbeck,
Sage Therapeutics,
Bright Minds Biosciences,
Vertex Pharmaceuticals,
Rayzebio,
Morphic Therapeutic,
Neurocrine Biosciences,
Dermata Therapeutics, Inc..
Longboard Pharmaceuticals's support email address is info@longboardpharma.com
Longboard Pharmaceuticals's categories are Biotechnology Research
Longboard Pharmaceuticals's founding year is 2020
